Trials / Completed
CompletedNCT06490991
Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects
A Clinical Study Evaluating the Relative Bioavailability of HRS-5965 Capsules and Tablets in Healthy Subjects .
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is designed as a single-center, randomized, open-label, cross-over phase I clinical trial with the intention of recruiting 16 healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-5965 tablets；HRS-5965 capsules | Medication regimen: 1 Drug: HRS-5965 tablets Medication regimen: 2 Drug: HRS-5965 capsules |
Timeline
- Start date
- 2024-07-17
- Primary completion
- 2024-08-06
- Completion
- 2024-09-10
- First posted
- 2024-07-08
- Last updated
- 2025-12-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06490991. Inclusion in this directory is not an endorsement.